Here's the live share price of Lupin along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Lupin has gained 16.77% CAGR. Over the past year, the corresponding return has been 1.10%.
Lupin’s current P/E of 22.02x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lupin | 1.61 | 1.62 | 1.64 | 3.70 | 1.10 | 41.93 | 16.77 |
| Sun Pharmaceutical Industries | 0.37 | 1.08 | 10.67 | 5.77 | -1.52 | 21.53 | 25.34 |
| Divi's Laboratories | 0.78 | -2.79 | 4.05 | -5.20 | 8.35 | 24.02 | 11.26 |
| Torrent Pharmaceuticals | -0.32 | -1.72 | 6.16 | 14.42 | 11.63 | 32.88 | 21.89 |
| Cipla | 0.62 | -2.36 | -3.74 | -1.76 | 3.57 | 11.25 | 13.78 |
| Dr. Reddy's Laboratories | 2.63 | 2.77 | -2.41 | -5.03 | 0.72 | 14.06 | 4.88 |
| Zydus Lifesciences | -0.65 | -2.18 | -11.70 | -6.17 | -7.50 | 30.86 | 14.27 |
| Mankind Pharma | -3.34 | -6.17 | -18.01 | -11.05 | -21.72 | 13.94 | 8.14 |
| Aurobindo Pharma | 1.20 | -4.96 | 7.68 | 2.79 | -5.56 | 38.60 | 6.07 |
| Alkem Laboratories | -0.05 | -1.07 | 2.81 | 16.33 | 4.06 | 22.89 | 14.34 |
| Abbott India | -1.06 | -6.01 | -10.15 | -12.11 | -1.54 | 10.48 | 11.34 |
| Glenmark Pharmaceuticals | 1.07 | 5.01 | -5.68 | 16.43 | 26.28 | 67.39 | 30.16 |
| Laurus Labs | -2.05 | -2.13 | 11.77 | 47.15 | 74.44 | 37.06 | 24.17 |
| Biocon | 0.17 | -8.81 | 6.69 | 7.53 | 8.64 | 13.04 | -3.54 |
| GlaxoSmithKline Pharmaceuticals | 1.27 | 4.07 | -5.33 | -22.99 | 13.76 | 24.52 | 10.81 |
| Anthem Biosciences | 2.36 | 1.27 | -18.88 | -7.73 | -7.73 | -2.65 | -1.60 |
| Ipca Laboratories | -1.71 | -2.53 | 8.90 | 4.69 | -8.88 | 18.58 | 4.86 |
| Ajanta Pharma | -0.99 | 3.60 | 1.60 | -0.11 | -10.51 | 29.76 | 18.13 |
| J B Chemicals & Pharmaceuticals | -0.40 | -1.78 | 6.36 | 3.17 | -1.82 | 19.09 | 26.95 |
| Gland Pharma | -2.89 | -8.37 | -17.74 | -6.01 | -3.96 | -0.56 | -5.41 |
Over the last one year, Lupin has gained 1.10% compared to peers like Sun Pharmaceutical Industries (-1.52%), Divi's Laboratories (8.35%), Torrent Pharmaceuticals (11.63%). From a 5 year perspective, Lupin has outperformed peers relative to Sun Pharmaceutical Industries (25.34%) and Divi's Laboratories (11.26%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,074.58 | 2,086.95 |
| 10 | 2,081.29 | 2,079.78 |
| 20 | 2,063.2 | 2,063.52 |
| 50 | 2,002.58 | 2,025.71 |
| 100 | 1,977.86 | 2,002.8 |
| 200 | 1,984.05 | 1,988.64 |
In the latest quarter, Lupin saw a drop in promoter holding to 46.90%, while DII stake increased to 26.56%, FII holding fell to 20.50%, and public shareholding moved down to 6.06% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 57,05,582 | 1.1 | 1,188.02 | |
| 46,15,980 | 2.37 | 961.14 | |
| 42,85,561 | 2.05 | 892.34 | |
| 42,00,000 | 0.93 | 874.52 | |
| 30,83,991 | 7.59 | 642.15 | |
| 28,35,782 | 3.21 | 590.47 | |
| 28,23,402 | 0.97 | 587.89 | |
| 26,87,887 | 1.73 | 559.67 | |
| 25,52,382 | 1.26 | 531.46 | |
| 25,20,027 | 1.05 | 524.72 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Dec 12, 2025, 5:18 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Dec 11, 2025, 11:16 PM IST | Lupin Ltd. - Newspaper Publication For The Information Regarding Special Window For Re-Lodgement For Transfer Request Of Phys |
| Dec 10, 2025, 9:44 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Dec 09, 2025, 11:31 PM IST | Lupin Ltd. - ESG Rating By NSE Sustainability Ratings & Analytics Limited. |
| Dec 05, 2025, 3:02 PM IST | Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Lupin Ltd. is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 16967.50 Cr. and Equity Capital is Rs. 91.32 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lupin is ₹2,085.00 as on Dec 16, 2025.
The Lupin is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Lupin is ₹95,242.55 Cr as on Dec 16, 2025.
Today’s highest and lowest price of Lupin are ₹2,100.50 and ₹2,078.15.
The 52-week high/low is the highest and lowest price at which Lupin stock has traded in the past 52-week or nearly a year. The 52-week high of Lupin is ₹2,403.45 and 52-week low of Lupin is ₹1,774.00 as on Dec 16, 2025.
The Lupin has shown returns of -0.25% over the past day, 1.62% for the past month, 1.64% over 3 months, 1.1% over 1 year, 41.93% across 3 years, and 16.77% over 5 years.
P/E ratio of and PB ratio of Lupin are 22.02 and 5.54 on Dec 16, 2025. While the company gives a dividend yield of 0.58 per annum.